GTR Test Accession:
Help
GTR000502383.1
Registered in GTR:
2013-05-24
View version history
GTR000502383.1,
registered in GTR:
2013-05-24
Last annual review date for the lab: 2024-10-29
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment; ...
Conditions (1):
Help
Cone dystrophy 3
Proteins (1):
Help
Codanin-1
Methods (1):
Help
Molecular Genetics - Linkage analysis: Microarray
Target population: Help
0-30
Clinical validity:
Help
Not provided
Clinical utility:
Help
Not provided
Ordering Information
Offered by:
Help
Specimen Source:
Help
- Buccal swab
- Isolated DNA
- Plasma
- Saliva
Who can order: Help
- Out-of-State Patients
Contact Policy:
Help
Post-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
Pre-test email/phone consultation regarding genetic test results and interpretation is provided to patients/families.
How to Order:
Help
Contact us: info@virtualeyecaremd.com
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
Confirmation of research findings
Custom Deletion/Duplication Testing
Genetic counseling
Confirmation of research findings
Custom Deletion/Duplication Testing
Genetic counseling
Test additional service:
Help
Custom mutation-specific/Carrier testing
Informed consent required:
Help
Decline to answer
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test Order Code,
Lab contact for this test,
Test strategy,
Test development
Conditions
Help
Total conditions: 1
Condition/Phenotype | Identifier |
---|
Test Targets
Proteins
Help
Total proteins: 1
Protein | Associated Condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument
Linkage analysis
Microarray
Illumina HiSeq™2000 system
Clinical Information
Test purpose:
Help
Diagnosis;
Mutation Confirmation;
Risk Assessment;
Screening
Target population:
Help
0-30
Recommended fields not provided:
Clinical validity,
Clinical utility,
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
3000, 0.98
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
No
No
Recommended fields not provided:
Test Confirmation,
Assay limitations,
Description of internal test validation method,
Citations for Analytical validity,
PT Provider,
Description of PT method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Not provided
Additional Information
Reviews:
Clinical resources:
Molecular resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.